Lung Cancer Clinical Trial

Clinician-Patient Communication in Lung Cancer Care

Summary

The purpose of this study is to better understand communication between patients with lung cancer and their clinicians. The investigators are also interested in patient's perceptions of the quality of communication with his/her clinician and how these perceptions may impact patient outcomes. The clinician participating in this study and has given us permission to approach his/her eligible patients for study participation.

View Eligibility Criteria

Eligibility Criteria

Inclusion Criteria:

Patients with confirmed lung cancer diagnosis or mass suspicious of lung cancer as per clinician report and/or EMR
Lung cancer diagnosis or suspicious mass as per clinician report/EMR within 0-6 months of consent or within no more than three visits to participating clinician
Participating clinician approves his/her patient's participation in this study per clinician report.
Former (at least 100 cigarettes in lifetime and quit more than 30 days prior to enrollment) or current smoker (lifetime smoker who reports cigarette smoking within the past 30 days) as per self report or EMR;
English fluency (determined through EMR or clinician report), as we do not have the resources to translate the consultations from other languages or the surveys to other languages;
Patients must be 18 years old or older

Clinician Inclusion Criteria:

An MSK attending physician (radiologists, medical oncologists, and surgeons), Nurse Practitioner (NP), Physician Assistant (PA), Fellow, Resident or Clinical Nurse Specialist (CNS) or Clinical Nurse (RN) who is a member of the Thoracic Disease Management Team or Pulmonary Service currently treating thoracic patients at MSK as per self report
Clinical has individual clinic consultations to discuss adult health assessment and/or smoking history with the target patient population: English-speaking, at least 18 years of age, has a suspicious lung mass or confirmed diagnosis, is a former/current smoker, has had no more than 3 visits with clinician or had diagnosis in past 6 months as per self-report.

Exclusion Criteria:

Clinician Exclusion Criteria

N/A

Study is for people with:

Lung Cancer

Estimated Enrollment:

294

Study ID:

NCT02732834

Recruitment Status:

Active, not recruiting

Sponsor:

Memorial Sloan Kettering Cancer Center

Check Your Eligibility

Let’s see if you might be eligible for this study.

What is your age and gender ?

Submit

There are 6 Locations for this study

See Locations Near You

Memorial Sloan Kettering Basking Ridge (Consent and follow-up only)
Basking Ridge New Jersey, , United States
Memorial Sloan Kettering Monmouth (Consent and follow-up only)
Middletown New Jersey, 07748, United States
Memorial Sloan Kettering Bergen (Consent and follow-up only)
Montvale New Jersey, 07645, United States
Memorial Sloan Kettering Commack (Consent and follow-up only)
Commack New York, 11725, United States
Memorial Sloan Kettering Westchester (Consent and follow-up only)
Harrison New York, 10604, United States
Memorial Sloan Kettering Cancer Center
New York New York, 10065, United States
Memorial Sloan Kettering Nassau (Consent and Follow-Up only)
Uniondale New York, 11553, United States

How clear is this clinincal trial information?

Study is for people with:

Lung Cancer

Estimated Enrollment:

294

Study ID:

NCT02732834

Recruitment Status:

Active, not recruiting

Sponsor:


Memorial Sloan Kettering Cancer Center

How clear is this clinincal trial information?

×

Introducing, the Journey Bar

Use this bar to access information about the steps in your cancer journey.

Please confirm you are a US based health care provider:

Yes, I am a health care Provider No, I am not a health care provider